SCHEMBL27190064

SCHEMBL27190064

O=[N+]([O-])c1cc(I)c2cccnc2c1O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.78
ALDH1A1 P00352 10/20 0.78
KDM4E B2RXH2 9/20 0.78
MEN1 O00255 8/20 0.78
KMT2A Q03164 8/20 0.78
CTSB P07858 5/20 0.78
IDO1 P14902 2/20 0.78
TDO2 P48775 2/20 0.78
GAA P10253 2/20 0.78
TDP1 Q9NUW8 7/20 0.70
LMNA P02545 7/20 0.70
HTT P42858 7/20 0.70
SMN1; SMN2 Q16637 6/20 0.70
L3MBTL1 Q9Y468 6/20 0.70
PKM P14618 3/20 0.70
POLB P06746 3/20 0.70
RECQL P46063 2/20 0.70
BLM P54132 2/20 0.70
CASP6 P55212 2/20 0.70
THRB P10828 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18300579 0.88 MAPT (1.00) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL8164006 0.88 MAPT (1.00) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL7960630 0.83 MAPT (0.79) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL27190087 0.82 KDM4E (0.78) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL27190082 0.82 MAPT (1.00) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL24716103 0.82 MAPT (0.78) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL2111476 0.82 MAPT (1.00) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL27190058 0.81 MAPT (0.76) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL27190190 0.80 MAPT (0.74) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL3064377 0.79 MAPT (0.72) MAPTALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4623914-A1 USE OF 8-HYDROXYQUINOLINE DERIVATIVE Jiangsu Yahong Meditech Co., Ltd. (CN) 2025-10-01 EP disclosed
CN-120035438-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2025-05-23 CN disclosed
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2024-07-25 US disclosed
WO-2024109684-A1 USE OF 8-HYDROXYQUINOLINE DERIVATIVE 江苏亚虹医药科技股份有限公司 2024-05-30 WO disclosed
CN-118059101-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2024-05-24 CN disclosed
EP-4349815-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2024-04-10 EP disclosed
CN-117043141-A 7-nitro-8-hydroxyquinoline derivative, preparation method and medical application thereof 江苏亚虹医药科技股份有限公司 2023-11-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF CYP3A7, UGT1A7, UGT2B7 MAPT 4416/4885ALDH1A1 1017/4885KDM4E 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.